Application 050698
- Type
- NDA
- Sponsor
- ABBVIE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 125MG/5ML | Yes | No |
| 002 | BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 250MG/5ML | Yes | No |
| 003 | BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 187MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050698-001 | BIAXIN | CLARITHROMYCIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | |
| N050698-002 | BIAXIN | CLARITHROMYCIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | |
| N050698-003 | BIAXIN | CLARITHROMYCIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 301d65b070ca… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clarithromycin | CLARITHROMYCIN | A-S Medication Solutions | 25debd85-0840-4f8d-9898-027772061dd2 | 2025-06-09 | Warnings, Adverse reactions | CLARITHROMYCIN |
| clarithromycin | CLARITHROMYCIN | Actavis Pharma, Inc. | d5be5f12-6392-4d7d-ab23-ebc205ac1a85 | 2025-05-30 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Coupler LLC | 2d6cfd87-9b8c-bba9-e063-6294a90aff5a | 2025-02-05 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | NuCare Pharmaceuticals,Inc. | 9143b79c-4c79-43ac-e053-2995a90ad708 | 2025-02-04 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | DirectRx | d22bd12c-737b-4aab-e053-2995a90aff60 | 2025-01-20 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Bryant Ranch Prepack | 27e02b77-4332-49e0-8d0c-a072cf5dff92 | 2024-05-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Proficient Rx LP | 28f60574-4ecd-441c-aebe-5b1d18033ef6 | 2024-02-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Bryant Ranch Prepack | 0c7d8391-50ef-4827-abe6-e0fc0c2f1636 | 2024-01-16 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Rising Pharma Holdings, Inc. | 0c4db97f-f4c9-4cac-9f12-9db1d967ebeb | 2024-01-05 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | A-S Medication Solutions | adba78c2-9e51-4bed-8c6a-6f977f79c40c | 2023-12-14 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Lannett Company, Inc. | 9bf207c0-86eb-4f3b-92e7-f65f3fccd5a7 | 2023-11-13 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Aurobindo Pharma Limited | 9aaffb41-408c-4372-8fd5-1d649450c0e9 | 2023-10-10 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Lannett Company, Inc. | 71a836d0-d60f-6418-e053-2a95a90aa6ef | 2023-09-22 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Sandoz Inc | 22457862-0f88-4be8-b507-1c8f264269f2 | 2023-09-13 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | A-S Medication Solutions | 1d6f5a9d-51b2-4e0d-b573-ccf08fe6ea23 | 2023-07-31 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Sandoz Inc | b98b02bb-2609-49a0-b29f-e5911aa0cbc1 | 2023-05-30 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Alembic Pharmaceuticals Limited | 268d21f9-02c9-41b0-9487-7968ea12720d | 2023-05-29 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Alembic Pharmaceuticals Inc. | cde51c9f-f7b8-413f-8b8e-e56370cd5754 | 2023-05-26 | Warnings, Adverse reactions | CLARITHROMYCIN |
| CLARITHROMYCIN | CLARITHROMYCIN | Chartwell RX, LLC. | 99d2fd6b-39ca-42f9-ad06-30e7fbc22c47 | 2022-12-23 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Proficient Rx LP | b1bdf526-4f16-4130-b614-4cb678f060d7 | 2021-01-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 60048 | SUPPL | 2019-09-19 |
| 60038 | SUPPL | 2019-09-19 |
| 56941 | SUPPL | 2018-12-31 |
| 56893 | SUPPL | 2018-12-20 |
| 56767 | SUPPL | 2018-12-18 |
| 56612 | SUPPL | 2018-11-30 |
| 48704 | SUPPL | 2017-06-12 |
| 48692 | SUPPL | 2017-06-12 |
| 18040 | SUPPL | 2016-06-01 |
| 30299 | SUPPL | 2016-05-31 |
| 18041 | SUPPL | 2015-10-29 |
| 30301 | SUPPL | 2015-10-28 |
| 39134 | SUPPL | 2015-01-12 |
| 8033 | SUPPL | 2015-01-09 |
| 39133 | SUPPL | 2014-08-07 |
| 30300 | SUPPL | 2014-07-28 |
| 30298 | SUPPL | 2013-09-11 |
| 8032 | SUPPL | 2013-09-11 |
| 18039 | SUPPL | 2013-09-09 |
| 18038 | SUPPL | 2013-09-09 |
| 18037 | SUPPL | 2012-07-10 |
| 8030 | SUPPL | 2012-07-10 |
| 30297 | SUPPL | 2012-06-05 |
| 30296 | SUPPL | 2012-05-09 |
| 8031 | SUPPL | 2012-05-09 |
| 39132 | SUPPL | 2012-05-07 |
| 18036 | SUPPL | 2012-05-07 |
| 39131 | SUPPL | 2011-05-31 |
| 39130 | SUPPL | 2011-05-31 |
| 30295 | SUPPL | 2011-05-31 |
| 8029 | SUPPL | 2011-05-31 |
| 8028 | SUPPL | 2009-11-20 |
| 39129 | SUPPL | 2009-09-22 |
| 8027 | SUPPL | 2008-05-29 |
| 30294 | SUPPL | 2008-01-09 |
| 18035 | SUPPL | 2007-12-27 |
| 44204 | ORIG | 2006-09-25 |
| 8026 | SUPPL | 2006-07-13 |
| 8025 | SUPPL | 2005-10-20 |
| 18034 | SUPPL | 2005-10-10 |
| 8024 | SUPPL | 2004-07-21 |
| 8023 | SUPPL | 2002-05-24 |